• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORBUSNEICH MEDICAL (SHENZHEN) CO., LTD. SAPPHIRE NC PLUS CORONARY DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORBUSNEICH MEDICAL (SHENZHEN) CO., LTD. SAPPHIRE NC PLUS CORONARY DILATATION CATHETER Back to Search Results
Catalog Number 235-183-2U
Device Problem Break (1069)
Patient Problem Stenosis (2263)
Event Type  Injury  
Event Description
Information from (b)(6) 2020: the sapphire nc plus balloon broke during removal.The fragment was removed with a snare.Information from (b)(6) 2020: "a lhc was performed from right common femoral access.After the heart cath images were obtained of the left lower extremity.It was determined that a focal stenosis was present at the origin of the at.At this point a 6f x 45cm destination sheath was placed up and over into the left sfa.A 0.014 grandslam wire was used to cross the at lesion.The stenosis was first pre-dilated with a 3mm mustang balloon, the lesion was noted to be unchanged.At this point the 3.5x18 sapphire nc balloon was advanced across the lesion and inflated to 12atms for 20 seconds.Then upon removal the physician felt no resistance but the shaft of the balloon broke leaving 2/3 of the balloon catheter inside the patient's leg.The sheath was then upsized to an 8f sheath.At this point multiple attempts were made to snare the catheter without success.Then left common femoral access was obtained and a snare was advanced.The physician was then able to snare the balloon catheter with a 35mm loop snare.At this point the balloon catheter, the snare system, and the sheath was removed all at the same time.Manual pressure was then held until hemostasis was obtained.The procedure was then continued.The at was wired again with a grandslam wire and a 4x40 nanocross was used to successful balloon the lesion.All equipment was removed and manual pressure was held on the right common femoral artery until hemostasis was obtained." patient has hx of htn and dmii.Additional information from 2/8/2020: no kinks or bends were noted during the advancement of the balloon catheter.No kinks or bends were noted during the removal of the balloon catheter.The catheter broke at the proximal shaft about 30-40cm down the catheter.The lesion was located at the origin of the at and 70% stenosed.The vessel was not tortuous, with minimal to no calcium noted on the angio.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SAPPHIRE NC PLUS CORONARY DILATATION CATHETER
Type of Device
CATHETER
Manufacturer (Section D)
ORBUSNEICH MEDICAL (SHENZHEN) CO., LTD.
no.1st jinkui road
futian free trade zone
shenzhen guangdong, shenzhen guangdong CN 5 1803
CH  CN 51803
MDR Report Key9909229
MDR Text Key196250599
Report Number3014148220-2020-00597
Device Sequence Number1
Product Code LOX
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Biomedical Engineer
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/01/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number235-183-2U
Device Lot Number3402251901
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/02/2020
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date02/05/2020
Event Location Hospital
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-